Susquehanna Fundamental Investments, LLC Capricor Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.8 - $5.23 $62,700 - $86,295	-16,500 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$3.16 - $5.72 $50,244 - $90,948	-15,900 Reduced 49.07%	16,500 $85,000
Q1 2021 May 17, 2021	BUY	$3.63 - $7.93 $117,612 - $256,932	32,400 New	32,400 $152,000
Q4 2020 Feb 16, 2021	SELL	$3.43 - $5.23 $55,308 - $84,333	-16,125 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.08 - $9.81 $46,410 - $111,588	-11,375 Reduced 41.36%	16,125 $85,000
Q2 2020 Aug 14, 2020	BUY	$1.0 - $8.5 $27,500 - $233,750	27,500 New	27,500 $127,000

6.33M

210K

374K

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $112M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.